Laurion Capital Management LP Verona Pharma PLC Transaction History
Laurion Capital Management LP
- $8.4 Billion
- Q2 2024
A detailed history of Laurion Capital Management LP transactions in Verona Pharma PLC stock. As of the latest transaction made, Laurion Capital Management LP holds 1,050,842 shares of VRNA stock, worth $35.9 Million. This represents 0.18% of its overall portfolio holdings.
Number of Shares
1,050,842
Previous 882,040
19.14%
Holding current value
$35.9 Million
Previous $14.2 Million
7.07%
% of portfolio
0.18%
Previous 0.12%
Shares
3 transactions
Others Institutions Holding VRNA
# of Institutions
145Shares Held
66.8MCall Options Held
495KPut Options Held
486K-
Ra Capital Management, L.P. Boston, MA7.63MShares$261 Million1.66% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$191 Million7.62% of portfolio
-
Deep Track Capital, LP Greenwich, CT4MShares$137 Million1.9% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.55MShares$121 Million7.58% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.31MShares$113 Million2.82% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $2.08B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...